EndoPredict Breast Cancer Prognostic Test

**Semantic type:** Laboratory Procedure

**Definition:** A prognostic genomic test that predicts individual risk of early and late breast cancer recurrence across years 0-15. It is intended for patients with ER+, HER2-, node negative or node positive breast cancer in early stages. The assay looks at the expression level of 3 proliferation-related genes, 5 receptor-related genes, 3 normalization genes, and one control gene and generates a risk score based on these, as well as tumor size and node status.

**Synonyms:** - EndoPredict